215 related articles for article (PubMed ID: 31721285)
1. Effects of Probiotics on Intestinal Failure-Associated Liver Disease in Adult Patients Receiving Prolonged Parenteral Support: A Tertiary Care Center Experience.
Alomari M; Nusairat L; Al Momani L; Chadalavada P; Covut F; Olayan M; Young M; Romero-Marrero C
Nutr Clin Pract; 2020 Jun; 35(3):454-463. PubMed ID: 31721285
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.
Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L
Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510
[TBL] [Abstract][Full Text] [Related]
3. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
4. Use of Mixed-Oil Fat Emulsion to Improve Intestinal Failure-Associated Liver Disease in Long-Term Home Parenteral Nutrition: A Case Report.
Hurt RT; Mundi MS
JPEN J Parenter Enteral Nutr; 2017 Nov; 41(1_suppl):17S-19S. PubMed ID: 29148930
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of home parenteral nutrition in patients with ultra-short bowel syndrome.
Diamanti A; Conforti A; Panetta F; Torre G; Candusso M; Bagolan P; Papa RE; Grimaldi C; Fusaro F; Capriati T; Elia D; De Ville de Goyet J
J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):438-42. PubMed ID: 24231643
[TBL] [Abstract][Full Text] [Related]
6. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
[TBL] [Abstract][Full Text] [Related]
7. Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.
Cheang LY; Chong NCJ; Poh BY; Tan LB; Goh JLR; Lee MS; Tan KCT; Kadir HA; Cheah CCM; Salazar E
Clin Nutr ESPEN; 2024 Jun; 61():140-144. PubMed ID: 38777425
[TBL] [Abstract][Full Text] [Related]
8. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center.
Abi Nader E; Lambe C; Talbotec C; Pigneur B; Lacaille F; Garnier-Lengliné H; Petit LM; Poisson C; Rocha A; Corriol O; Aigrain Y; Chardot C; Ruemmele FM; Colomb-Jung V; Goulet O
Am J Clin Nutr; 2016 May; 103(5):1327-36. PubMed ID: 27030532
[TBL] [Abstract][Full Text] [Related]
9. Parenteral Nutrition and Intestinal Failure.
Bielawska B; Allard JP
Nutrients; 2017 May; 9(5):. PubMed ID: 28481229
[TBL] [Abstract][Full Text] [Related]
10. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Fibrosis in Intestinal Failure-Associated Liver Disease in the Sustain Registry.
Wang J; Wamuo O; Micic D
JPEN J Parenter Enteral Nutr; 2020 Sep; 44(7):1285-1290. PubMed ID: 31990095
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Intestinal Failure: The Key Outcomes for the First 100 Patients Treated in a National Tertiary Referral Center During 1984-2017.
Merras-Salmio L; Mutanen A; Ylinen E; Rintala R; Koivusalo A; Pakarinen MP
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1304-1313. PubMed ID: 29701871
[TBL] [Abstract][Full Text] [Related]
14. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis.
Diamond IR; de Silva NT; Tomlinson GA; Pencharz PB; Feldman BM; Moore AM; Ling SC; Wales PW
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5):596-602. PubMed ID: 21825088
[TBL] [Abstract][Full Text] [Related]
15. Reversal of Intestinal Failure-Associated Liver Disease by Increasing Fish Oil in a Multi-Oil Intravenous Lipid Emulsion in Adult Short Bowel-Syndrome Patients.
Park HJ; Lee S; Park CM; Yoo K; Seo JM
JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):204-207. PubMed ID: 32181905
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease.
Taha AM; Sharif K; Johnson T; Clarke S; Murphy MS; Gupte GL
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):547-51. PubMed ID: 22167020
[TBL] [Abstract][Full Text] [Related]
17. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
Carter BA; Karpen SJ
Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Failure-Associated Liver Disease.
Pironi L; Sasdelli AS
Clin Liver Dis; 2019 May; 23(2):279-291. PubMed ID: 30947877
[TBL] [Abstract][Full Text] [Related]
19. Hepatic ultrastructure in a neonatal piglet model of intestinal failure-associated liver disease (IFALD).
Hua Z; Sergi C; Nation PN; Wizzard PR; Ball RO; Pencharz PB; Turner JM; Wales PW
J Electron Microsc (Tokyo); 2012 Jun; 61(3):179-86. PubMed ID: 22366032
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
